Evidence map›Paper›PMID 42438375›Full record

GuidelineThe Medical journal of Australia2026

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

Nicole M Rankin, Rebecca Zosel, Lisa J Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A R Lantin, Georgia Bartlett, Mikayla Wolfe and 21 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in The Medical journal of Australia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Nicole M RankinMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Rebecca ZoselMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Lisa J WhopYardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0003-4816-2933
Raglan MaddoxYardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0002-2770-0686
Annette McWilliamsDepartment of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Miranda SiemienowiczNorthern Imaging, Victoria Northern Health NCHER, Epping, Victoria, Australia.
Jon EmeryPopulation and Global Health, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.ORCID https://orcid.org/0000-0002-5274-6336
Maria A R LantinMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0009-0007-3782-2912
Georgia BartlettMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Mikayla WolfeYardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.ORCID https://orcid.org/0009-0007-7660-3990
Abbey DiazYardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.
Katrina AndersonCancer Australia, Sydney, New South Wales, Australia.
Lillian LiuCancer Australia, Sydney, New South Wales, Australia.
Cindy TomsCancer Australia, Sydney, New South Wales, Australia.
Sarah McDermottNational Aboriginal Community Controlled Health Organisation, Canberra, Australian Capital Territory, Australia.
Peter BlighNational Aboriginal Community Controlled Health Organisation, Canberra, Australian Capital Territory, Australia.
Jeremy ChalkeNational Aboriginal Community Controlled Health Organisation, Canberra, Australian Capital Territory, Australia.
Stephen MelsomDepartment of Medical Imaging, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Claire E NightingaleMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Alison BrownMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-2407-842X
Sam PopeYardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.
Julia BrothertonMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-2304-3105
Anne FidlerLung Foundation Australia, Milton, Queensland, Australia.
Michel ItelLung Foundation Australia, Milton, Queensland, Australia.
Mark BrookeLung Foundation Australia, Milton, Queensland, Australia.
Diane M PascoeDepartment of Medical Imaging, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Fraser BrimsCurtin Medical School, Curtin University, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-6725-7535
Tracy L LeongDepartment of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Emily StoneDepartment of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
Dorothy KeefeCancer Australia, Sydney, New South Wales, Australia.
Vivienne MilchCancer Australia, Sydney, New South Wales, Australia.

Funding

Cancer Australia
6 · The paper itself

Abstract

introductionLung cancer is the leading cause of cancer mortality in Australia. In July 2025, the Australian Government launched the National Lung Cancer Screening Program (the Program). The Program has been designed in accordance with the Medical Services Advisory Committee's recommendations. This article summarises the program guidelines, outlining Program parameters and delivery requirements. The screening and assessment pathway defines the Program structure. The purpose of the guidelines is to ensure safe, effective and high-quality Program delivery, detailing key steps for clinical practice and information for participating healthcare providers. MAIN RECOMMENDATIONS: The guidelines provide recommendations for the delivery of targeted low-dose CT screening for lung cancer in the Australian context. Program eligibility is assessed using risk-based eligibility criteria recommended by the Medical Services Advisory Committee, targeting people between 50 and 70 years of age with a history of tobacco cigarette smoking. Smoking cessation supports are to be offered to all potential participants by healthcare providers across the lung cancer screening and assessment pathway. Low-dose CT scan assessment and reporting follow the National Lung Cancer Screening Program's nodule management protocol. CHANGES IN MANAGEMENT AS A RESULT OF THE GUIDELINE: This guideline provides recommendations for the delivery of targeted low-dose CT screening for lung cancer in the Australian context. Content includes: guidance on assessing Program eligibility; enrolling eligible participants in the National Cancer Screening Register; completing and fulfilling low-dose CT scan requests; assessing and reporting low-dose CT scan results; managing scan outcomes and actionable additional findings; and communicating scan results. The full guideline is available at https://www.health.gov.au/resources/publications/nlcsp-guidelines.

Indexed as

Early Detection of CancerLung NeoplasmsMass ScreeningAgedAustraliaHumansMiddle AgedPractice Guidelines as TopicSmoking CessationTomography, X-Ray Computedcancerearly detection of cancermass screeningpopulation healthpopulation policyprevention and controlprimary carepublic healthpublic policyrespiratory tract neoplasms

Identifiers

PMID42438375
PMCPMC13358458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.